UY26819A1 - Derivados de pirazol - Google Patents

Derivados de pirazol

Info

Publication number
UY26819A1
UY26819A1 UY26819A UY26819A UY26819A1 UY 26819 A1 UY26819 A1 UY 26819A1 UY 26819 A UY26819 A UY 26819A UY 26819 A UY26819 A UY 26819A UY 26819 A1 UY26819 A1 UY 26819A1
Authority
UY
Uruguay
Prior art keywords
derivatives
new
pirazol derivatives
pyrazole derivatives
pirazol
Prior art date
Application number
UY26819A
Other languages
English (en)
Inventor
Anthony Wood
Manoussos Perros
Romuald G Corbau
Charles E Mowbray
Paul A Stupple
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of UY26819A1 publication Critical patent/UY26819A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Esta invención se refiere al uso de derivados de pirazol de fórmula (I) y a las sales y solvatos farmacéuticamente aceptables de ésto, en la fabricación de un inhibidor o modulador de transcriptasa inversa, a ciertos de dichos derivados de pirazol nuevos, a procedimientos para su preparación y a composiciones que contienen dichos nuevos derivados
UY26819A 2000-07-07 2001-07-06 Derivados de pirazol UY26819A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0016787.4A GB0016787D0 (en) 2000-07-07 2000-07-07 Compounds useful in therapy

Publications (1)

Publication Number Publication Date
UY26819A1 true UY26819A1 (es) 2002-01-31

Family

ID=9895273

Family Applications (1)

Application Number Title Priority Date Filing Date
UY26819A UY26819A1 (es) 2000-07-07 2001-07-06 Derivados de pirazol

Country Status (20)

Country Link
US (2) US6750230B2 (es)
EP (1) EP1299361B1 (es)
JP (1) JP2004502760A (es)
AP (1) AP2001002204A0 (es)
AT (1) ATE333445T1 (es)
AU (1) AU2001267766A1 (es)
BR (1) BR0112252A (es)
CA (1) CA2415492A1 (es)
DE (1) DE60121590T2 (es)
ES (1) ES2266212T3 (es)
GB (1) GB0016787D0 (es)
GT (1) GT200100132A (es)
HN (1) HN2001000146A (es)
MX (1) MXPA03000059A (es)
PA (1) PA8521701A1 (es)
PE (1) PE20020131A1 (es)
SV (1) SV2002000520A (es)
TN (1) TNSN01102A1 (es)
UY (1) UY26819A1 (es)
WO (1) WO2002004424A1 (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6455559B1 (en) 2001-07-19 2002-09-24 Pharmacia Italia S.P.A. Phenylacetamido-pyrazole derivatives, process for their preparation and their use as antitumor agents
NZ529403A (en) 2001-04-10 2005-06-24 Pfizer Pyrazole derivatives for treating HIV
GB0113524D0 (en) 2001-06-04 2001-07-25 Hoffmann La Roche Pyrazole derivatives
EP1465871A1 (en) * 2001-12-28 2004-10-13 Bayer Corporation Pyrazole derivatives for use in diseases associated with the 5-ht2c receptor
AU2003217712A1 (en) 2002-03-07 2003-09-22 Smithkline Beecham Corporation Pyrazolopyrimidine and pyrazolotriazine derivatives and pharmaceutical compositions containing them
UA79804C2 (en) * 2002-07-03 2007-07-25 Janssen Pharmaceutica Nv Cck-1 receptor modulators
GB0221477D0 (en) * 2002-09-16 2002-10-23 Pfizer Ltd Chemical compounds
US20040132793A1 (en) * 2002-09-16 2004-07-08 Pfizer Inc. Pyrazole derivatives
US7230025B2 (en) 2002-09-26 2007-06-12 Pfizer, Inc. Pyrazole derivatives
JP2006505625A (ja) 2002-09-26 2006-02-16 ファイザー・インク Ｈｉｖ感染症を治療するためのピラゾールアミド
GB0223234D0 (en) * 2002-10-07 2002-11-13 Pfizer Ltd Chemical compounds
US6933312B2 (en) 2002-10-07 2005-08-23 Agouron Pharmaceuticals, Inc. Pyrazole derivatives
GB0223232D0 (en) * 2002-10-07 2002-11-13 Pfizer Ltd Chemical compounds
PL377848A1 (pl) 2003-02-07 2006-02-20 Daiichi Pharmaceutical Co., Ltd. Pochodne pirazoli
TW200423930A (en) 2003-02-18 2004-11-16 Hoffmann La Roche Non-nucleoside reverse transcriptase inhibitors
JP2006526015A (ja) * 2003-05-02 2006-11-16 エラン ファーマシューティカルズ，インコーポレイテッド 炎症疾患治療のためのブラジキニンｂ１受容体アンタゴニストとしての４−ブロモ−５−（２−クロロ−ベンゾイルアミノ）−１ｈ−ピラゾール−３−カルボン酸アミド誘導体および関連化合物
US7220772B2 (en) 2003-09-05 2007-05-22 Pfizer, Inc. Pyrazole derivatives
EP1740550A1 (en) * 2004-04-14 2007-01-10 Pfizer Limited Sulphur-linked imidazole compounds for the treament of hiv
WO2005118543A1 (ja) * 2004-06-03 2005-12-15 Ono Pharmaceutical Co., Ltd. キナーゼ阻害薬およびその用途
US7531560B2 (en) * 2004-11-10 2009-05-12 Boehringer Ingelheim Pharmaceuticals, Inc. Anti-cytokine heterocyclic compounds
JP2008526828A (ja) * 2005-01-06 2008-07-24 ファイザー・リミテッド 逆転写酵素モジュレーターとしてのイミダゾール誘導体
US7923465B2 (en) 2005-06-02 2011-04-12 Glenmark Pharmaceuticals S.A. Cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation
EP2308852A1 (de) 2005-08-21 2011-04-13 Abbott GmbH & Co. KG 5-Ring-Heteroaromaten-Verbindungen und ihre Verwendung als Bindungspartner für 5-HT5-Rezeptoren
PL2035390T3 (pl) * 2006-07-05 2016-06-30 Merial Inc Związki będące pochodnymi 1-arylo-5-alkilopirazolu, sposoby ich wytwarzania i zastosowania
ES2360893T3 (es) 2006-08-16 2011-06-10 F. Hoffmann-La Roche Ag Inhibidores no nucleósidos de la transcriptasa inversa.
AU2008267895A1 (en) 2007-06-22 2008-12-31 F. Hoffmann-La Roche Ag Urea and carbamate derivatives as non-nucleoside reverse transcriptase inhibitors
AU2008340422B2 (en) 2007-12-21 2014-06-19 F. Hoffmann-La Roche Ag Heterocyclic antiviral compounds
CN102271672B (zh) 2008-11-19 2015-02-04 梅里亚有限公司 用于治疗寄生物感染的包含单独的或与甲脒组合的1-芳基吡唑的组合物
US9173728B2 (en) 2008-11-19 2015-11-03 Merial Inc. Multi-cavity container having offset indentures for dispensing fluids
US8748435B2 (en) 2011-04-01 2014-06-10 Novartis Ag Pyrazolo pyrimidine derivatives
CN103588707B (zh) * 2013-06-09 2016-06-01 中国科学院上海有机化学研究所 多氮化合物及其合成方法
JOP20180092A1 (ar) * 2017-10-13 2019-04-13 Gilead Sciences Inc مثبطات hiv بروتياز
KR20210022048A (ko) * 2018-06-18 2021-03-02 바이엘 악티엔게젤샤프트 이치환된 3-피라졸 카르복실레이트, 및 에놀레이트의 아실화를 통한 그의 제조 방법
IL310395A (en) 2021-08-02 2024-03-01 Syngenta Crop Protection Ag Microbiocidal pyrazole derivatives
CN118368986A (zh) 2021-12-17 2024-07-19 先正达农作物保护股份公司 杀微生物的吡唑衍生物
WO2024068947A1 (en) 2022-09-30 2024-04-04 Syngenta Crop Protection Ag Microbiocidal pyrazole derivatives
WO2024156886A1 (en) 2023-01-27 2024-08-02 Syngenta Crop Protection Ag Microbiocidal pyrazole derivatives
WO2024160801A1 (en) 2023-02-01 2024-08-08 Syngenta Crop Protection Ag Fungicidal compositions

Family Cites Families (121)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3154543A (en) 1961-09-18 1964-10-27 Norwich Pharma Co Preparation of 5-aminofurans
DE1261124B (de) 1961-09-22 1968-02-15 Hoechst Ag Verfahren zur Herstellung von Pyrazolen
US3303200A (en) * 1963-11-05 1967-02-07 American Home Prod Pyrazole-1-ethanol derivatives
JPS5030871A (es) 1973-07-16 1975-03-27
US3960836A (en) 1974-07-22 1976-06-01 Eli Lilly And Company Acylated derivatives of pyrazofurin and process for their preparation
US4041046A (en) 1975-06-06 1977-08-09 American Cyanamid Company 1,2-Dialkyl-3,4,5-trisubstituted pyrazole compounds
SU657745A3 (ru) 1976-06-09 1979-04-15 Санкио Компани Лимитед, (Фирма) Способ получени производных пиразола или их солей или эфиров органических кислот
DE2829289A1 (de) 1978-07-04 1980-01-24 Basf Ag Pyrazolaetherderivate
JPS5533413A (en) 1978-08-29 1980-03-08 Ishihara Sangyo Kaisha Ltd Pyrazole derivative and herbicide containing the same
JPS5535037A (en) 1978-09-04 1980-03-11 Sankyo Co Ltd Herbicidal composition
JPS5535038A (en) 1978-09-04 1980-03-11 Sankyo Co Ltd Weed controlling composition
JPS5535036A (en) 1978-09-04 1980-03-11 Sankyo Co Ltd Herbicidal composition
JPS5535039A (en) 1978-09-04 1980-03-11 Sankyo Co Ltd Weed controlling composition
JPS5535035A (en) 1978-09-04 1980-03-11 Sankyo Co Ltd Herbicidal composition
JPS5547602A (en) 1978-10-25 1980-04-04 Sankyo Co Ltd Herbicide
JPS577403A (en) 1980-06-17 1982-01-14 Ishihara Sangyo Kaisha Ltd Herbicide for paddy field
JPS58185568A (ja) 1982-04-24 1983-10-29 Nissan Chem Ind Ltd ピラゾ−ル誘導体，その製造方法および該誘導体を含有する選択性除草剤
JPS58188858A (ja) 1982-04-27 1983-11-04 Mitsubishi Petrochem Co Ltd 新規ピラゾ−ル誘導体
JPS5988470A (ja) 1982-11-15 1984-05-22 Nippon Nohyaku Co Ltd ピラゾ−ル誘導体及び除草，殺ダニ剤
JPS59104362A (ja) 1982-12-07 1984-06-16 Nissan Chem Ind Ltd ピラゾ−ル誘導体、その製造方法および該誘導体を含有する選択性除草剤
JPS59122472A (ja) 1982-12-29 1984-07-14 Nissan Chem Ind Ltd ピラゾ−ル誘導体、その製造方法および該誘導体を含有する選択性除草剤
JPS59196869A (ja) * 1983-04-22 1984-11-08 Sankyo Co Ltd ピラゾ−ル誘導体及び除草剤
NZ208555A (en) 1983-06-23 1987-06-30 American Cyanamid Co (3-amino-1h-pyrazol-4-yl)-arylmethanone derivatives
JPS608204A (ja) 1983-06-29 1985-01-17 Nissan Chem Ind Ltd 除草組成物
JPS608208A (ja) 1983-06-29 1985-01-17 Nissan Chem Ind Ltd 除草用組成物
JPS608207A (ja) 1983-06-29 1985-01-17 Nissan Chem Ind Ltd 除草剤組成物
JPS6016974A (ja) 1983-07-09 1985-01-28 Nissan Chem Ind Ltd ピラゾ−ル誘導体，その製造方法および選択性除草剤
JPS6034902A (ja) 1983-08-05 1985-02-22 Nissan Chem Ind Ltd 除草性組成物
JPH0680047B2 (ja) 1983-08-24 1994-10-12 日産化学工業株式会社 ピラゾールスルホニルウレア誘導体、その製法および該誘導体を含有する選択性除草剤
JPS6064903A (ja) 1983-09-21 1985-04-13 Nissan Chem Ind Ltd 除草剤組成物
JPS60197605A (ja) 1984-03-19 1985-10-07 Nissan Chem Ind Ltd 除草剤組成物
JPS60202803A (ja) 1984-03-28 1985-10-14 Tokuyama Soda Co Ltd 除草剤組成物
DE3575130D1 (de) 1984-05-12 1990-02-08 Fisons Plc Antiinflammatorische 1,n-diarylpyrazol-3-amine, deren zusammensetzungen und verfahren zu deren herstellung.
JPS6115802A (ja) 1984-06-29 1986-01-23 Nissan Chem Ind Ltd 除草剤組成物
JPS61148105A (ja) 1984-12-21 1986-07-05 Tokuyama Soda Co Ltd 除草剤組成物
US4656260A (en) 1984-12-27 1987-04-07 Kanto Ishi Pharmaceutical Co., Ltd. Cyclic pyrazolo C-nucleoside compound and process for preparing the same
US4744815A (en) 1985-05-11 1988-05-17 Nissan Chemical Industries, Ltd. 4-benzoyl-1-alkyl (alkenyl) - pyrazoles, composition containing them, herbicidal method of using them, and intermediate in their preparation
DE3602728A1 (de) 1985-05-17 1986-11-20 Bayer Ag, 51373 Leverkusen Schaedlingsbekaempfungsmittel auf basis von pyrazolderivaten
DE3520330A1 (de) 1985-06-07 1986-12-11 Bayer Ag, 5090 Leverkusen 5-amino-1-pyridyl-pyrazole
DE3529829A1 (de) 1985-08-21 1987-02-26 Bayer Ag 1-arylpyrazole
JPH0655645B2 (ja) 1985-12-09 1994-07-27 ダイセル化学工業株式会社 除草剤組成物
DE3545036A1 (de) 1985-12-19 1987-09-10 Bayer Ag 5-heterocyclyl-1-aryl-pyrazole
JPS62145003A (ja) 1985-12-19 1987-06-29 Sumitomo Chem Co Ltd 除草組成物
DE3600287A1 (de) 1986-01-08 1987-07-16 Bayer Ag 1-arylpyrazole
DE3603291A1 (de) 1986-02-04 1987-08-06 Bayer Ag 5-amino-1-phenyl-pyrazole
DE3606476A1 (de) 1986-02-28 1987-09-03 Bayer Ag 1-arylpyrazole
DE3617554A1 (de) 1986-05-24 1987-11-26 Bayer Ag 5-oxy(thio)-pyrazol-derivate
JPS6351304A (ja) 1986-08-19 1988-03-04 Nissan Chem Ind Ltd 除草剤組成物
EP0264773A1 (en) 1986-10-16 1988-04-27 American Cyanamid Company 4,5-dihydro and 4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidines
EP0272704A3 (en) 1986-12-26 1990-11-22 Sanwa Kagaku Kenkyusho Co., Ltd. Use of pyrazole derivatives in the treatment of immunity diseases and nephropathy
DE3711928A1 (de) 1987-04-09 1988-10-20 Bayer Ag Substituierte 1-arylpyrazole
JPS6413072A (en) 1987-07-07 1989-01-17 Fuji Photo Film Co Ltd Production of 3-alkoxy-5-amino-1h-pyrazoles
US4769907A (en) 1987-07-27 1988-09-13 Northern Telecom Limited Method of making a circuit board pin
DE3724920A1 (de) 1987-07-28 1989-02-09 Bayer Ag Substituierte 1-aryl-5-(het)arylmethylamino-pyrazole
JPH01113304A (ja) 1987-10-28 1989-05-02 Daikin Ind Ltd 除草剤組成物
JPH01211582A (ja) 1988-02-16 1989-08-24 Tanabe Seiyaku Co Ltd ベンゾジオキソール誘導体
JPH01210003A (ja) 1988-02-18 1989-08-23 Daicel Chem Ind Ltd 芳香族ポリスルホン中空糸膜ならびにその製造法
JP2622707B2 (ja) 1988-02-19 1997-06-18 日本カーバイド工業株式会社 アルミ建材の再塗装方法
JPH0296472A (ja) 1988-09-30 1990-04-09 Matsushita Graphic Commun Syst Inc 画像データ縮小方法
GB2224208A (en) 1988-10-20 1990-05-02 Shell Int Research Fungicidal pyrazolyl aryl ketones
JP2694369B2 (ja) 1989-11-27 1997-12-24 京セラ株式会社 窒化珪素質焼結体
US5063245A (en) 1990-03-28 1991-11-05 Nova Pharmaceutical Corporation Corticotropin-releasing factor antagonism compounds
DE4023215A1 (de) 1990-07-21 1992-01-23 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, sie enthaltende mittel und deren verwendung
DE4023488A1 (de) 1990-07-24 1992-01-30 Bayer Ag 1-(pyri(mi)dyl-(2)) -5-hydroxy-pyrazol-mikrobizide
JP2753659B2 (ja) 1990-09-03 1998-05-20 株式会社大塚製薬工場 ピラゾール誘導体
JPH0532662A (ja) 1990-11-09 1993-02-09 Nissan Chem Ind Ltd 置換ピラゾール誘導体および農園芸用殺菌剤
CZ129493A3 (en) 1990-12-31 1994-03-16 Monsanto Co Elimination of pesticides influence on plants
PH30258A (en) 1991-12-30 1997-02-05 Janssen Pharmaceutica Nv Heterocycle-substituted benzenemethanamine derivatives
JPH05262741A (ja) 1992-01-09 1993-10-12 Nissan Chem Ind Ltd フェニルピラゾール誘導体および有害生物防除剤
WO1993015060A1 (en) 1992-01-22 1993-08-05 Nissan Chemical Industries, Ltd. Substituted pyrazole derivative and agrohorticultural bactericide
FR2687675B1 (fr) 1992-01-31 1997-04-18 Roussel Uclaf Nouveaux derives bicycliques de la pyridine, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
AU3497293A (en) 1992-02-26 1993-09-13 F. Hoffmann-La Roche Ag Benzodiazepinones and medicines containing them
GB9207591D0 (en) 1992-04-07 1992-05-20 Glaxo Group Ltd Chemical processes
US5264451A (en) 1992-04-07 1993-11-23 American Home Products Corporation Process for treating hyperglycemia using trifluoromethyl substituted 3H-pyrazol-3-ones
US5274111A (en) 1992-04-07 1993-12-28 American Home Products Corporation Trifluoromethyl substituted 1H-pyrazoles and derivatives thereof
JPH0665237A (ja) 1992-05-07 1994-03-08 Nissan Chem Ind Ltd 置換ピラゾール誘導体および農園芸用殺菌剤
EP0577025A3 (de) 1992-07-01 1998-02-04 Hoechst Aktiengesellschaft Angiotensin-II-Rezeptorantagonisten zur Behandlung und Prophylaxe von koronaren Herzerkrankungen
EP0577023A3 (en) 1992-07-01 1996-12-18 Hoechst Ag Angiotensin-ii receptor-antagonists for the treatment of arrhythmices
JPH0625177A (ja) 1992-07-09 1994-02-01 Nissan Chem Ind Ltd ピラゾール誘導体及び除草剤
KR0170567B1 (ko) 1992-12-17 1999-02-18 알렌 제이. 스피겔 부신피질자극호르몬-유리 인자 길항물질 활성을 갖는 피라졸 및 피라졸로피리미딘
EP0959074A3 (en) * 1992-12-17 2000-06-07 Pfizer Inc. Substituted pyrazoles as CRF antagonists
US6103900A (en) 1992-12-17 2000-08-15 Pfizer Inc Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
TW336932B (en) 1992-12-17 1998-07-21 Pfizer Amino-substituted pyrazoles
US6005109A (en) 1997-10-30 1999-12-21 Pflizer Inc. Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
JP3170374B2 (ja) 1993-01-14 2001-05-28 山本化成株式会社 フルオラン化合物及びこの化合物を含有する記録材料
JPH06239864A (ja) 1993-02-15 1994-08-30 Fujisawa Pharmaceut Co Ltd 新規複素環誘導体
WO1994022830A1 (en) 1993-03-31 1994-10-13 Smithkline Beecham Corporation Chemical compounds
DE4333659C2 (de) 1993-10-02 2003-11-06 Guenter Ege 4-Arylmethyl-1H-pyrazol-3-amine, deren Salze und Verfahren zu ihrer Herstellung
JPH07165724A (ja) 1993-12-13 1995-06-27 Nkk Corp ピラゾール誘導体及び血液凝固阻害剤
DE69408950T2 (de) 1993-12-14 1998-10-15 Mitsubishi Chem Corp N-Pyrazolylcarbamatderivate und Fungizide für Landwirtschaft und Gartenbau, die diese als aktive Bestandteile erhalten, Produktion und Zwischenprodukte
JPH07224041A (ja) 1994-02-10 1995-08-22 Mitsubishi Chem Corp ピラゾリル酢酸誘導体およびこれを有効成分とする農園芸用殺菌剤
DE4411235A1 (de) 1994-03-31 1995-10-05 Bayer Ag Thiazolylpyrazolinone
JP3791015B2 (ja) 1994-03-31 2006-06-28 日産化学工業株式会社 スルホンアミド誘導体の製造方法
AU2547895A (en) 1994-05-13 1995-12-05 Sanofi Winthrop, Inc. Therapeutic phenoxyalkylheterocycles
US5646152A (en) * 1994-06-15 1997-07-08 Pfizer Inc. Methods of administering CRF antagonists
CA2200316C (en) * 1994-09-26 2004-09-21 Hirohiko Sugimoto Imidazole derivative
AU664686B3 (en) 1994-11-15 1995-11-23 Efisio Theo Pettena A road barrier for a vehicle
US5663199A (en) 1994-11-30 1997-09-02 Uniroyal Chemical Ltd./Ltee Anti-viral aromatic O-alkylated oximes, ethers and thioethers
US5550280A (en) 1994-11-30 1996-08-27 Uniroyal Chemical Ltd./ Uniroyal Chemical Ltee Hindered aromatic ester compounds useful as anti-viral agents
JP3734180B2 (ja) 1994-12-28 2006-01-11 エーザイ株式会社 新規ピラゾール誘導体
JPH08208620A (ja) 1995-02-03 1996-08-13 Takeda Chem Ind Ltd アミノピラゾール誘導体、その製造法および用途
EP0822187A4 (en) 1995-02-07 1998-05-13 Nissan Chemical Ind Ltd PYRAZOLE DERIVATIVES AS HERBICIDES
DE19518054A1 (de) 1995-03-08 1996-09-12 Hoechst Schering Agrevo Gmbh N-Arylpyrazolketone und deren Derivate, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel
EP0833622B8 (en) 1995-06-12 2005-10-12 G.D. Searle & Co. Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
DE19521822A1 (de) 1995-06-16 1996-12-19 Dresden Arzneimittel Neue, antikonvulsiv wirkende 3-Aminopyrazole, Verfahren zu deren Herstellung und ihre Verwendung
JPH0995482A (ja) 1995-09-29 1997-04-08 Shionogi & Co Ltd α−置換酢酸を有する複素環誘導体、その製造用中間体ならびにそれを含有する農薬
GB2310207A (en) 1996-02-15 1997-08-20 Pharmacia Spa Antiviral ureido derivatives of substituted heterocyclic compounds
FR2745467A1 (fr) 1996-03-04 1997-09-05 Rhone Poulenc Agrochimie Pyrazoles contre les virus des plantes
US6011052A (en) 1996-04-30 2000-01-04 Warner-Lambert Company Pyrazolone derivatives as MCP-1 antagonists
DE19622189A1 (de) 1996-06-03 1997-12-04 Bayer Ag 3-Cyanaryl-pyrazole
DE19629826A1 (de) 1996-07-24 1998-01-29 Bayer Ag 1,3-Dimethyl-5-fluor-pyrazol-4-carboxamide
GB9625045D0 (en) * 1996-11-30 1997-01-22 Pfizer Ltd Parasiticidal compounds
US6020357A (en) 1996-12-23 2000-02-01 Dupont Pharmaceuticals Company Nitrogen containing heteroaromatics as factor Xa inhibitors
JP4123542B2 (ja) 1997-07-07 2008-07-23 住友化学株式会社 ピラゾリノン誘導体の製造法
DE19827855A1 (de) 1998-06-23 1999-12-30 Hoechst Schering Agrevo Gmbh Kombinationen aus Herbiziden und Safenern
DE19829616A1 (de) 1998-07-02 2000-01-05 Bayer Ag Verfahren zur Herstellung von 1-Alkyl-pyrazol-5-carbonsäureestern
JP2000053649A (ja) 1998-08-11 2000-02-22 Sumitomo Pharmaceut Co Ltd スルホニルウレイドピラゾール誘導体
DE19837067A1 (de) 1998-08-17 2000-02-24 Bayer Ag Verfahren zur Herstellung von 1-Alkyl-pyrazol-5-carbonsäureestern
JPH11228312A (ja) 1998-10-16 1999-08-24 Mitsubishi Chemical Corp 水性懸濁状除草剤原液組成物
FR2795726A1 (fr) 1999-06-30 2001-01-05 Aventis Cropscience Sa Nouveaux pyrazoles fongicides
CA2315614C (en) * 1999-07-29 2004-11-02 Pfizer Inc. Pyrazoles

Also Published As

Publication number Publication date
HN2001000146A (es) 2002-01-11
WO2002004424A1 (en) 2002-01-17
MXPA03000059A (es) 2003-10-15
DE60121590D1 (en) 2006-08-31
US6750230B2 (en) 2004-06-15
TNSN01102A1 (fr) 2005-11-10
AP2001002204A0 (en) 2001-09-30
CA2415492A1 (en) 2002-01-17
JP2004502760A (ja) 2004-01-29
ATE333445T1 (de) 2006-08-15
GT200100132A (es) 2002-03-22
ES2266212T3 (es) 2007-03-01
SV2002000520A (es) 2002-12-02
US20040209862A1 (en) 2004-10-21
EP1299361B1 (en) 2006-07-19
AU2001267766A1 (en) 2002-01-21
PA8521701A1 (es) 2002-08-26
WO2002004424A9 (en) 2002-12-12
DE60121590T2 (de) 2006-11-30
US7141585B2 (en) 2006-11-28
PE20020131A1 (es) 2002-02-21
GB0016787D0 (en) 2000-08-30
BR0112252A (pt) 2003-09-02
US20020032184A1 (en) 2002-03-14
EP1299361A1 (en) 2003-04-09

Similar Documents

Publication Publication Date Title
UY26819A1 (es) Derivados de pirazol
CU23240B7 (es) Derivados de 2-aminocarbonil-9h-purina
CR7069A (es) Derivados de pirazol para el tratamiento de vih
DOP2006000193A (es) Compuestos de isoindol-imida y composiciones que los incluye y metodos para su uso
UY27516A1 (es) Bencimidazoles
AR031130A1 (es) N-acilsulfonamidas promotoras de la apoptosis
PA8506301A1 (es) Cristal de 4- carboxamino- 1,2,3,4,- tetrahidroquinolina 2-sustituida
AR023423A1 (es) Derivados de adamantano, procedimientos para su preparacion, composicion farmaceutica, procedimiento para la preparacion de la composicion farmaceutica, yuso de dichos derivados para la manufactura de medicamentos
HN2002000300A (es) Nuevos derivados de piperazina
HN2002000198A (es) Composiciones farmaceuticas de amlodipina y atorvastatina
ECSP066426A (es) Nuevos derivados de pirimidin-2-amina
PA8582801A1 (es) Nuevos derivados espirotricíclicos y su uso como inhibidores de la fosfodiesterasa
PA8529501A1 (es) Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa -7."
CR7956A (es) Oxazolidinonas de indolona antibacterial intermedios para su preparacion y composiciones farmaceuticas que contienen los mismos
GT200500340A (es) Derivados de octahidropirrolo [3,4-c] pirrol
HN2001000235A (es) Derivados puentes de piperazina
PA8586801A1 (es) Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
AR041340A1 (es) Derivados de tiazolpirimidinona,proceso de preparacion y composiciones farmaceuticas que los contienen
ECSP034531A (es) Derivados sustituidos de c-ciclohexilmetilamina
AR003451A1 (es) Derivados de piperazina, una composicion farmaceutica que los comprende, el uso de los mismos y un metodo para su preparacion.
AR026350A1 (es) Derivados de isoxazol como inhibidores de la fosfodiesterasa vii
HN1999000101A (es) Inhibidores de las fkbp.
ES2182090T3 (es) Nuevos derivados de pirrol.
ES2189072T3 (es) Nuevo benzo-cicloalquenos heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
HN2000000056A (es) Nuevas formas cristalinas de un antibiotico macrolido

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20140428